Clinical trial Recruiting at 1 site Observational Ages 18 and up

A large biobank for acute and emergency medicine

Official title: Acutelines: a Large Biobank Aiming to Improve Early Recognition of Acute Diseases, Contribute to the Development of Personalized Medicine and Optimize Short- and Long-term Outcome

Run by University Medical Center Groningen · NCT04615065 · Data updated 2026-11-12

This study is collecting health information and samples from patients with sudden illnesses in the Emergency Department to see if it can help improve treatments and predict how patients will do.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment35000 (estimated)
SponsorUniversity Medical Center Groningen
Academic / other
Locations1 site (Groningen)
StatusRecruiting
StartedSeptember 1, 2020
Main results expectedSeptember 1, 2030
Study endsSeptember 1, 2030
Registry record updatedJune 13, 2024
Trial IDNCT04615065 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study include patients triaged as red or orange in the Manchester triage system, or those with specific acute conditions such as sepsis or acute kidney injury.

Probably not a fit

Patients referred for organ transplantation or those transferred from other hospitals may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Acutelines is a prospective biobank designed to collect extensive data and biomaterials from patients presenting with a variety of acute conditions at the Emergency Department. The initiative aims to enhance the understanding of acute diseases and improve treatment outcomes through interdisciplinary research. By systematically gathering clinical data, imaging, and biomaterials over time, the project seeks to develop personalized treatment strategies and predict patient outcomes more effectively. The study employs a deferred consent procedure to facilitate data collection while ensuring patient rights are respected.

Why it matters

Potential benefit: If successful, this biobank could lead to improved recognition and treatment of acute diseases, ultimately enhancing patient outcomes.

How similar studies have gone: Other studies utilizing biobanks for acute conditions have shown promise, but this specific approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria, at least one of the following:

* Triaged as one of highest two triage categories (red or orange) according to the Manchester triage system;
* Triaged as the third highest triage category (yellow) and arrival by EMS of Helicopter Emergency Medical Service (HEMS;
* Shock
* Suspicion of sepsis (based on either physicians' suspicion, Sepsis-2 or Sepsis-3 criteria)
* Acute kidney injury (AKI)
* Anaphylactic reaction
* Syncope
* Intoxication
* Thrombosis
* Pulmonary embolism
* Bleeding while using anti-coagulant drugs
* Gastro-intestinal bleeding
* Electrolyte disturbance

Exclusion Criteria:

* Referred for organ transplantation as recipient
* Transfer from other hospital
* Accidental contact patient material (i.e. internal work-related accident)

While data- and imaging will be collected from all these patients, biomaterials will only be collected from patients fulfilling the first criterion (i.e. triaged as one of highest two triage categories \[red or orange\] according to the Manchester triage system) and from patients with shock or a suspicion of sepsis.

Where it's running

  • University Medical Center Groningen
    Groningen, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.